股本结构
单位：万股
| 公告日期 | 2026-07-30 | 2026-07-30 | 2026-04-28 | 2026-05-05 | 2026-02-26 | 2026-02-26 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3839.28 | 3834.57 | 3819.91 | 3819.05 | 3816.01 | 3789.06 |
| 普通股本 | 3839.28 | 3834.57 | 3819.91 | 3819.05 | 3816.01 | 3789.06 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-07-23 | 2026-06-30 | 2026-04-22 | 2026-03-31 | 2026-02-19 | 2025-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-07-30 | 3839.28 | 未披露 | 定期报告 | 2026-07-23 |
| 2026-07-30 | 3834.57 | 未披露 |
更多>>
From March 31,2026 to June 30,2026
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
|
2026-06-30 |
| 2026-04-28 | 3819.91 | 未披露 | 定期报告 | 2026-04-22 |
| 2026-05-05 | 3819.05 | 未披露 |
更多>>
From December 31,2025 to March 31,2026
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
|
2026-03-31 |
| 2026-02-26 | 3816.01 | 未披露 | 定期报告 | 2026-02-19 |
| 2026-02-26 | 3789.06 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
Sale of common stock in underwritten offerings,net of issuance costs of $28,978
Sale of common stock in at-the-market offering,net of issuance costs of $302
|
2025-12-31 |
| 2025-11-06 | 3775.02 | 未披露 | 定期报告 | 2025-10-31 |
| 2025-10-22 | 3807.21 | 未披露 |
更多>>
Common Stock offered 3,065,477 shares by the company
|
2025-10-22 |
| 2025-11-06 | 3500.66 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
Sale of common stock in at-the-market offering, net of issuance costs of $302
|
2025-09-30 |
| 2025-08-07 | 3476.56 | 未披露 | 定期报告 | 2025-07-31 |
| 2025-08-07 | 3469.49 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
|
2025-06-30 |
| 2025-05-07 | 3463.43 | 未披露 | 定期报告 | 2025-04-30 |
| 2025-04-24 | 3463.29 | 未披露 | 定期报告 | 2025-04-15 |
| 2025-05-07 | 3458.12 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Issuance of common stock upon exercise of stock options
Sale of common stock in underwritten offering, net of issuance costs of $15,321
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
|
2025-03-31 |
| 2025-02-27 | 3456.90 | 未披露 | 定期报告 | 2025-02-21 |
| 2025-01-23 | 3367.59 | 未披露 |
更多>>
Common stock offered by company 3,918,182 shares.
|
2025-01-24 |
| 2025-02-27 | 2986.50 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Sale of common stock in an underwritten offering, net of issuance costs of $5,472
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon exercise of stock options
Sale of common stock in at-the-market offerings, net of issuance costs of $518
|
2024-12-31 |
| 2024-11-12 | 2975.77 | 未披露 | 定期报告 | 2024-11-07 |
| 2024-11-12 | 2974.82 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon exercise of stock options
|
2024-09-30 |
| 2024-08-08 | 2972.58 | 未披露 | 定期报告 | 2024-08-05 |
| 2024-11-15 | 2970.80 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common stock upon exercise of stock options
Sale of common stock in registered direct offering, net of issuance costs of $5,472
|
2024-06-30 |
| 2024-06-14 | 2966.57 | 未披露 |
更多>>
Common stock offered 4,944,000 shares by the company
|
2024-06-17 |
| 2024-05-09 | 2472.17 | 未披露 | 定期报告 | 2024-05-06 |
| 2024-05-01 | 2472.15 | 未披露 | 定期报告 | 2024-04-15 |
| 2024-05-09 | 2469.59 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of common stock upon exercise of stock options
Sale of common stock in at-the-market offerings, net of issuance costs of $518
Issuance of common stock under employee stock purchase plan
|
2024-03-31 |
| 2024-03-21 | 2468.10 | 未披露 | 定期报告 | 2024-02-29 |
| 2024-03-21 | 2436.02 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock upon exercise of stock options
Sale of common stock in follow-on public offering, net of issuance costs of $9,272
Issuance of common stock upon exercise of warrants
Vesting of restricted common stock
Sale of common stock in registered direct offering, net of issuance costs of $80
Sale of common stock in at-the-market offerings, net of issuance costs of $742
|
2023-12-31 |
| 2023-11-09 | 2414.04 | 未披露 | 定期报告 | 2023-11-07 |
| 2023-11-09 | 2413.91 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
|
2023-09-30 |
| 2023-08-11 | 2287.76 | 未披露 | 定期报告 | 2023-08-08 |
| 2023-08-11 | 2285.09 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock upon exercise of stock options
Vesting of restricted common stock
Sale of common stock in at-the-market offerings, net of issuance costs of $119
Sale of common stock in follow-on public offering, net of issuance costs of $9,272
|
2023-06-30 |
| 2023-06-15 | 2239.53 | 未披露 |
更多>>
Common Stock offered by the company 2,595,919 shares
|
2023-06-16 |
| 2023-05-15 | 1979.94 | 未披露 | 定期报告 | 2023-05-10 |
| 2023-04-20 | 1979.39 | 未披露 | 定期报告 | 2023-04-14 |
| 2023-05-15 | 1957.52 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Sale of common stock in registered direct offering, net of issuance costs of $80
Issuance of common stock upon exercise of stock options
Vesting of restricted common stock
Sale of common stock in at-the-market offerings, net of issuance costs of $408
|
2023-03-31 |
| 2023-03-31 | 1899.80 | 未披露 | 定期报告 | 2023-02-28 |
| 2023-01-18 | 1740.56 | 未披露 | 定期报告 | 2023-01-04 |
| 2023-03-31 | 1740.33 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Vesting of restricted common stock
Conversion of preferred stock to common stock
Issuance of common stock to Roche
Issuance of common stock upon exercise of stock options
Issuance of common stock for cash in pre-closing financing
Issuance of common stock to Gemini shareholders in reverse recapitalization
|
2022-12-31 |
| 2022-12-29 | 1692.33 | 未披露 |
更多>>
Disc Medicine, Inc. announced today that its previously-announced merger with Gemini Therapeutics, Inc. (“Gemini”) closed on December 29, 2022, following the approval of Gemini shareholders. The combined company, focused on advancing Disc’s pipeline of hematology programs, will operate under the name Disc Medicine, Inc. and its shares will commence trading on a 1-10 reverse split adjusted basis effective with the open of business on December 30, 2022 on the Nasdaq Global Market under the ticker symbol IRON.
|
2022-12-30 |
| 2022-11-10 | 4332.83 | 未披露 | 定期报告 | 2022-11-04 |
| 2022-11-10 | 4329.95 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Vesting of restricted common stock
Issuance of common stock upon exercise of stock options
|
2022-09-30 |
| 2022-08-11 | 4324.45 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock upon exercise of stock options
Proceeds from sale of stock under employee stock purchase plan
|
2022-06-30 |
| 2022-05-06 | 4322.72 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock upon exercise of stock options
|
2022-03-31 |
| 2022-03-10 | 4320.82 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Retroactive application of the recapitalization due to the Business Combination
Issuance of common stock upon Business Combination, net of issuance costs
Conversion of promissory notes
Issuance of common stock upon exercise of warrants
Vesting of restricted common stock
Issuance of common stock upon exercise of stock options
|
2021-12-31 |
| 2021-11-15 | 4311.27 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock upon exercise of stock options
|
2021-09-30 |
| 2021-08-12 | 4310.95 | 未披露 | 定期报告 | 2021-08-10 |
| 2021-08-12 | 4305.51 | 未披露 |
更多>>
from March 31, 2021 to June 30, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted common stock
|
2021-06-30 |
| 2021-05-13 | 4305.29 | 未披露 | 定期报告 | 2021-05-11 |
| 2021-05-13 | 4300.21 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Retroactive application of the recapitalization due to the Business Combination
|
2021-03-31 |
| 2021-03-29 | 4299.87 | 未披露 | 定期报告 | 2021-03-29 |
| 2021-03-29 | 4299.87 | 未披露 | 定期报告 | 2021-03-15 |
| 2021-02-17 | 4530.20 | 未披露 | 定期报告 | 2021-02-05 |
| 2020-11-12 | 1553.53 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Sale of shares in initial public offering, gross
Sale of private placement shares to Sponsor in private placement
Common stock subject to possible redemption
|
2020-09-30 |
| 2020-08-13 | 1353.50 | 未披露 |
更多>>
1.Shares of Class A common stock offered 10,500,000 shares
|
2020-08-12 |
From March 31,2026 to June 30,2026
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
From December 31,2025 to March 31,2026
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
From December 31, 2024 to December 31, 2025
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
Sale of common stock in underwritten offerings,net of issuance costs of $28,978
Sale of common stock in at-the-market offering,net of issuance costs of $302
Common Stock offered 3,065,477 shares by the company
From June 30, 2025 to September 30, 2025
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
Sale of common stock in at-the-market offering, net of issuance costs of $302
From March 31, 2025 to June 30, 2025
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
From December 31, 2024 to March 31, 2025
Issuance of common stock upon exercise of stock options
Sale of common stock in underwritten offering, net of issuance costs of $15,321
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
Common stock offered by company 3,918,182 shares.
From December 31, 2023 to December 31, 2024
Sale of common stock in an underwritten offering, net of issuance costs of $5,472
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon exercise of stock options
Sale of common stock in at-the-market offerings, net of issuance costs of $518
From June 30, 2024 to September 30, 2024
Issuance of common stock under employee stock purchase plan
Issuance of common stock upon exercise of stock options
From March 31, 2024 to June 30, 2024
Issuance of common stock upon exercise of stock options
Sale of common stock in registered direct offering, net of issuance costs of $5,472
Common stock offered 4,944,000 shares by the company
From December 31, 2023 to March 31, 2024
Issuance of common stock upon exercise of stock options
Sale of common stock in at-the-market offerings, net of issuance costs of $518
Issuance of common stock under employee stock purchase plan
From December 31, 2022 to December 31, 2023
Issuance of common stock upon exercise of stock options
Sale of common stock in follow-on public offering, net of issuance costs of $9,272
Issuance of common stock upon exercise of warrants
Vesting of restricted common stock
Sale of common stock in registered direct offering, net of issuance costs of $80
Sale of common stock in at-the-market offerings, net of issuance costs of $742
From June 30, 2023 to September 30, 2023
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
From March 31, 2023 to June 30, 2023
Issuance of common stock upon exercise of stock options
Vesting of restricted common stock
Sale of common stock in at-the-market offerings, net of issuance costs of $119
Sale of common stock in follow-on public offering, net of issuance costs of $9,272
Common Stock offered by the company 2,595,919 shares
From December 31, 2022 to March 31, 2023
Sale of common stock in registered direct offering, net of issuance costs of $80
Issuance of common stock upon exercise of stock options
Vesting of restricted common stock
Sale of common stock in at-the-market offerings, net of issuance costs of $408
From December 31, 2021 to December 31, 2022
Vesting of restricted common stock
Conversion of preferred stock to common stock
Issuance of common stock to Roche
Issuance of common stock upon exercise of stock options
Issuance of common stock for cash in pre-closing financing
Issuance of common stock to Gemini shareholders in reverse recapitalization
Disc Medicine, Inc. announced today that its previously-announced merger with Gemini Therapeutics, Inc. (“Gemini”) closed on December 29, 2022, following the approval of Gemini shareholders. The combined company, focused on advancing Disc’s pipeline of hematology programs, will operate under the name Disc Medicine, Inc. and its shares will commence trading on a 1-10 reverse split adjusted basis effective with the open of business on December 30, 2022 on the Nasdaq Global Market under the ticker symbol IRON.
From June 30, 2022 to September 30, 2022
Vesting of restricted common stock
Issuance of common stock upon exercise of stock options
From March 31, 2022 to June 30, 2022
Issuance of common stock upon exercise of stock options
Proceeds from sale of stock under employee stock purchase plan
From December 31, 2021 to March 31, 2022
Issuance of common stock upon exercise of stock options
From December 31, 2020 to December 31, 2021
Retroactive application of the recapitalization due to the Business Combination
Issuance of common stock upon Business Combination, net of issuance costs
Conversion of promissory notes
Issuance of common stock upon exercise of warrants
Vesting of restricted common stock
Issuance of common stock upon exercise of stock options
From June 30, 2021 to September 30, 2021
Issuance of common stock upon exercise of stock options
from March 31, 2021 to June 30, 2021
Issuance of common stock upon exercise of stock options
Vesting of restricted common stock
From December 31, 2020 To March 31, 2021
Retroactive application of the recapitalization due to the Business Combination
From June 30, 2020 to September 30, 2020
Sale of shares in initial public offering, gross
Sale of private placement shares to Sponsor in private placement
Common stock subject to possible redemption
1.Shares of Class A common stock offered 10,500,000 shares